David Weill - 03 Dec 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
03 Dec 2025
Transactions value $
-$622,200
Form type
4
Filing time
05 Dec 2025, 16:30:04 UTC
Previous filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weill David Director C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER By: /s/ Gerardo Hernandez, Attorney-in-Fact 05 Dec 2025 0001774270

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $71K +5K +41.21% $14.20 17.1K 03 Dec 2025 Direct
transaction TMDX Common Stock Sale -$693K -5K -29.18% $138.64 12.1K 03 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5K -50% $0.00 5K 03 Dec 2025 Common Stock 5K $14.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested.